Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-24

Clinical Trial Update: Gabapentin Treatment of Benzodiazepine Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial update on using gabapentin for benzodiazepine dependence; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Benzodiazepine Dependence | Phase 2 | Status: TERMINATED | Results posted: 2018-07-24